Types of Cancer We Treat

Colorectal Cancer

Our medical, surgical, and radiation oncologists, gastroenterologists, and radiologists provide comprehensive, coordinated treatment and seamless care for people with even the most complex colorectal cancers, all under one roof. We personalize your treatment plan based on the location of the tumor, how advanced it is, and its molecular and genetic features.

Our clinical trials provide new and promising treatment options for people with early and more advanced colorectal cancer. NYU Langone doctors also offer high-quality colon cancer screening at convenient locations throughout the New York City area.

Find a Doctor & Schedule
Diagnosis
Preventive Treatment
Surgery
Chemotherapy
Immunotherapy & Targeted Therapies
Radiation Therapy

Related News

Newly Identified Gene Plays a Role in Colorectal Cancer
Read Story
Circulating Tumor DNA for Colorectal Cancer Treatment
Read Story
Raising Awareness for Colorectal Cancer Screenings
Read Story
Artificial Intelligence Enhances Colonoscopy Effectiveness
Read Story
Colorectal Cancer Cases Are Rising in Younger Adults
Read Story
New Score May Identify People at Risk of Colorectal Cancer
Read Story
COVID-19 Delayed Cancer Care for Vulnerable Populations
Read Story
Dr. Aasma Shaukat Joins NYU Langone Health
Read Story
Public Health Expert Works to Improve Cancer Health Equity
Read Story
Initiative Seeks to Stamp Out Cancer in Brooklyn
Read Story
Cohen Foundation Gift Expands Colorectal Cancer Screening
Read Story
Black Americans Urged to Get Regular Colon Cancer Screening
Read Story

Clinical Trials and Research Studies

Phase 6

NRG-GI008: COLON ADJUVANT CHEMOTHERAPY BASED ON EVALUATION OF RESIDUAL DISEASE (CIRCULATE-US)

Learn More

Phase 1

A Phase 1a/1b Study of LY3537982 in Patients with KRAS G12C-Mutant Advanced Solid Tumors

Learn More

Phase 6

A Phase 2/3 Randomized Open-Label Study of Maintenance GRT-C901/GRT-R902 A Neoantigen Vaccine in Combination with Immune Checkpoint Blockade for Patients with Metastatic Colorectal Cancer

Learn More

Phase 5

A Phase 1/2a Multi-Center Open-Label Study to Evaluate the Safety Tolerability Pharmacokinetics and Preliminary Evidence of Antitumor Activity of JAB-3312 in combination with pembrolizumab or binimetinib in Adult Patients with Advanced Solid Tumors

Learn More
View All Related Clinical Trials (17)